Far Eastern New Century Corporation

National Health Research Institutes

Der-Ren Hwang

Cheng-Ting Wang

Chiung-Tong Chen

Chu-Chung Lin

Wen-Tai Li

Shu-Jen Chen

Ming-Chu Hsu

Hsiao-Chan Wang

Yen-Hsien Li

Hsin-Hui Cheng

Chih-Chien Lin

Lin-Chien Yu

Chun-Chieh Chien

Kang-Rui Liu

Li-Ting Lu

A copolyester having a low melting point and a high crystallinity includes a first recurring unit, a second recurring unit, and a third recurring unit, which are respectively represented by Formulas (I), (II), and (III) defined herein. A molar ratio of the first recurring unit to the second recurring unit ranges from 1:0.5 to 1:3, and a molar ratio of the first recurring unit to the third recurring unit ranges from 1:1.3 to 1:8. The copolyester may have a melting point lower than 220&#xb0; C. and a lattice enthalpy greater than 12 J/g. A process for producing the copolyester and a fiber made from the copolyester are also disclosed.

Copolyester having low melting point and high crystallinity

A process for producing a cationic dyeable polyester includes the steps of:

Process for producing a cationic dyeable polyester and the cationic dyeable polyester produced thereby

A process for producing a flame-retardant polyester includes step (a) and step (b). In step (a), a combination of a bis-hydroxy alkyl terephthalate monomer and an organic diacid monomer mixture which includes an aromatic dicarboxylic acid monomer and a carboxy-phosphinic acid monomer is subjected to an esterification reaction to form an esterification reaction product. In step (b), the esterification reaction product is subjected to a polycondensation reaction.

Process for producing a flame-retardant polyester

A stabilizer for producing a polyester resin comprises a phosphate ester composition which includes a phosphate ester compound having Formula (I), wherein and 

Stabilizer for producing a polyester resin, process for preparing the same, process for producing the polyester resin using the same, and the polyester resin produced thereby

A process for reducing diethylene glycol formation in polyethylene terephthalate includes (a) subjecting a mixture of bis(2-hydroxyethyl)terephthalate with aromatic polycarboxylic acid to an esterification reaction, and (b) subjecting the esterification reaction product to polycondensation.

Process for reducing diethylene glycol formation in polyethylene terephthalate

A process for preparing bis(2-hydroxyethyl) terephthalate, comprising a step of: subjecting ethylene oxide and terephthalic acid in a molar ratio of from 2:1 to 3:1 to a reaction at an elevated temperature in the presence of a solvent mixture containing water and a C-Chydrocarbon in a weight ratio of from 1:1 to 3:1.

Process for preparing bis(2-hydroxyethyl) terephthalate

A method for preparing a stabilizer containing phosphate ester, including following steps: (1) distributing a compound containing phosphorous and oxide in polar aprotic solvent to obtain a mixture; (2) adding bis(2-hydroxyethyl) terephthalate (BHET) into the mixture to carry out a reaction so as to obtain a solution; and (3) hydrolyzing the solution to obtain a stabilizer containing phosphate ester, where the stabilizer includes compounds represented by the following formulas (I) and (II): where X, Xand Xare independently selected from the moiety represented by following formula (III), and Rand Rare independently selected from one of the linear or branched alkylene radicals comprising 2 to 4 carbon atoms The method yields a phosphate ester containing a phosphate monoester and a phosphate diester of a high content and only a minor amount of phosphoric acid in the absence of phosphate triester without the step of extraction.

Method for preparing stabilizer containing phosphate-ester

The present disclosure provides a method of manufacturing bis(2-hydroxyethyl) cyclohexane-1,4-dicarboxylate (BHCD) and derivatives thereof. The method includes the following steps. A first reactant including bis-hydroxyethyl terephthalate (BHET) is provided. 2-(2-hydroxyethoxy)ethyl 2-hydroxyethyl terephthalate (BHEET) is added to the first reactant including BHET to form a second reactant. The second reactant is hydrogenated.

Method of manufacturing BHCD and derivatives thereof

The present invention provides a biologically pure culture of, which culture has a characteristic nature capable of highly producing lactic acid. A method for preparing the biologically pure culture and a method for production of lactic acid are also provided.

Yeast strain for lactic acid production by using pentose and hexose

This invention relates to treating cancer or an angiogenesis-related disease using a compound of formula 1: wherein R, R, R, R, and n are defined herein.

Methods of 1H-indol-3-yl-2-oxoacetamide compounds

The invention relates to novel imidazolamino compounds. Also disclosed are methods of treating cancer by using one of these compounds and pharmaceutical compositions containing one of these compounds.

Imidazolamino compounds

A method of treating cancer including administering to a subject in need thereof an effective amount of a compound of the formula 1: wherein R, R, R, R, and n are as defined herein.

Use of 1H-indol-3-yl-2-oxoacetamide compounds

The invention is based on the discovery that certain 3-oxoacetamideindolyl compounds have potent anticancer and anti-angiogenic activity. The 3-oxoacetamideindolyl compounds are of the following formula.In this formula, each Ris independently isoxazolyl, thiazolyl, isothiazolyl, 1,3,4-thiadiazolyl, 1,3-benzothiazolyl, quinolyl, isoquinolyl, thionaphthenyl, or benzofuranyl, each being optionally substituted with 1-6 independent R; or when taken together with Rand the nitrogen atom to which they are attached form a 5-8 membered ring comprising C, N, S, or O atoms wherein any atom is optionally substituted with an independent R. Each Ris independently H, C1-C10 alkyl, or aryl, each being optionally substituted with 1-4 independent R; or when taken together with Rand the nitrogen atom to which they are attached form a 5-8 membered ring comprising C, N, S, or O atoms wherein any atom is optionally substituted with an independent R. Each Ris independently C3-C10 cycloalkyl, C4-C10 cycloalkenyl, isoxazolyl, furanyl, thiophenyl, thiazolyl, imidazolyl, pyridyl, or heterocyclyl, each being optionally substituted with 1-4 independent R. Each Ris independently H, NO, halo, CN, R, OR, COR, SR, NRR, C(O)R, C(O)NRR, OC(O)R, S(O)R, S(O)NRR, NRC(O)NRR, NRC(O)R, NR(COOR), NRS(O)NRR, NRS(O)R, or S(O)OR.

Growing community of inventors

Taipei, Taiwan

Der-Ren Hwang